EJCTS Click here to locate an Ethicon representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akar, H.
Right arrow Articles by Kolbakir, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akar, H.
Right arrow Articles by Kolbakir, F.
Related Collections
Right arrow Extracorporeal circulation
Right arrow Myocardial protection

Eur J Cardiothorac Surg 2001;19:500-506
© 2001 Elsevier Science NL

Comparison of histopathologic effects of carnitine and ascorbic acid on reperfusion injury

Haci Akara, Atilla Saraça, Cüneyt Konuralpb, Levent Yildizc, Fersat Kolbakira

a Ondokuz Mayis University, Faculty of Medicine, Department of Cardiovascular Surgery, Samsun, Turkey
b Siyami Ersek Thoracic and Cardiovascular Surgery Center, Department of Cardiovascular Surgery, Istanbul, Turkey
c Ondokuz Mayis University, Faculty of Medicine, Department of Pathology, Samsun, Turkey

Received 12 December 2000; received in revised form 6 February 2001; accepted 7 February 2001.

Corresponding author. Aye Çavus Sokak, No. 7/6, Huri Apartments, Suadiye, 81070, Istanbul, Turkey. Tel.:/fax: +90-216-363-3642
e-mail: ckonuralp{at}usa.net

Objective: Reperfusion injury can be seen after acute arterial occlusion, acute myocardial infarctus and during open heart surgery and vascular surgery. Protective effects of ascorbic acid and carnitine on reperfusion damage were tested and compared using histopathologic examination on ischemia model in the rabbit hind limb. Methods: Four groups (each containing ten animals) were used. In group I (G1), only anesthesia was administered and a biopsy was taken from the soleus muscle after 6 h. In group II (G2), group III (G3), and group IV (G4), after induction of anesthesia, arterial blood circulation of right posterior extremity was blocked by a tourniquet proximally. After four hours of ischemia, just before releasing of tourniquet, physiologic saline solution, sodium ascorbate (Redoxan) and L-carnitine (Carnitine) were administered intravenously to G2, G3 and G4, respectively. Following 2 h of reperfusion, biopsies were taken from soleus muscles. All of the biopsy slides were observed under the light microscope from the aspect of six different histopathologic criteria (loss of striation, nuclear centralisation, formation of ring and/or splitting, changing on diameters of muscle fibers, necrosis and minimal fibrosis) of ischemic muscle. Results: Ischemic change criteria were seen less frequency in both vitamin C and carnitine groups compared to the control and placebo groups. However, this protective effect was statistically significant only for the aspect of segmental necrosis, centralization of nuclei and diameter change parameters in G3 and in G4. When G3 and G4 were compared, the differences on protective effects were significant only from the aspect of fibrosis (P<0.001) and changing on diameter of the fibers (P<0.001). Conclusions: Both sodium ascorbate and carnitine are effective on reducing the reperfusion injury in skeletal muscle. But when we compared these two agents to each other, we found that carnitine seems a little more protective on our experimental model.

Key Words: Reperfusion • Ischemia • Carnitine • Ascorbic acid • Muscle




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Awad, E. I. Dedkov, C. Jiao, S. Bloomer, R. J. Tomanek, and G. C. Schatteman
Differential Healing Activities of CD34+ and CD14+ Endothelial Cell Progenitors
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 758 - 764.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.